Format

Send to

Choose Destination
Ann Thorac Surg. 2015 Oct;100(4):1496-504. doi: 10.1016/j.athoracsur.2015.06.048. Epub 2015 Aug 29.

Aortic Valve Replacement With the Stentless Freedom SOLO Bioprosthesis: A Systematic Review.

Author information

1
Department of Cardiothoracic Surgery, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. Electronic address: 1.w.wollersheim@amc.nl.
2
Department of Cardiothoracic Surgery, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
3
Department of Cardiology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
4
Department of Cardiac Surgery, University of Brescia Medical School, Brescia, Italy.

Abstract

This systematic review examined the clinical and hemodynamic performance of the stentless Freedom SOLO (Sorin Group, Milan, Italy) aortic bioprosthesis. The occurrence of postoperative thrombocytopenia was also analyzed. The Freedom SOLO is safe to use in everyday practice, with short cross-clamp times, and postoperative pacemaker implantation is notably lower. Valvular gradients are low and remain stable during short-term follow-up. Thrombocytopenia is more severe than in other aortic prostheses; however, this is without clinical consequences. Within a few years, the 15-year follow-up of this bioprosthesis will be known, which will be key to evaluating its long-term durability.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center